NCT02131662.
Trial name or title | Bay1002670, Fibroids, Safety and Efficacy EU, US, Can, Jap (ASTEROID 1) |
Methods | Randomised controlled trial |
Participants | Premenopausal women with heavy menstrual bleeding and fibroid ≥ than 3 cm |
Interventions | Vilaprisan 0.5 mg, 1 mg, 2 mg, 4 mg vs placebo |
Outcomes | Amenorrhoea at 3 months |
Starting date | May 2014 |
Contact information | Bayer |
Notes |